Related Experiment Video
Updated: Jan 8, 2026

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
Published on: March 24, 2023
Biotinidase deficiency deterioration in the second decade, presenting as treatable cerebellar ataxia and
Vykuntaraju K Gowda1, Anagha C Badrinath2, Varunvenkat M Srinivasan2
1Paediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India drknvraju08@gmail.com.
Abstract:
Biotinidase deficiency (BTD) is an inherited metabolic disorder with neurological, dermatological and metabolic manifestations. Clinical deterioration in adequately treated older children is uncommon and raises concerns regarding drug non-compliance, dosage adequacy or, rarely, evolving disease mechanisms. Here we report a middle childhood female with BTD diagnosed based on low biotinidase levels from infancy, and on supplementation with biotin. The patient presented with ataxia and encephalopathy following a febrile illness. The work-up for autoimmune, demyelinating and infectious aetiologies was negative, and later she had one episode of acute metabolic crisis. The child's non-compliance with biotin for the last 3 months, and on restarting the child on biotin, along with symptomatic management of acute metabolic crisis, the child recovered. Drug non-compliance and management of acute metabolic crisis during intercurrent illness need to be emphasised. Knowledge of late-onset manifestations that can mimic demyelinating disorders prevents unnecessary workup.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
08:41Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
Related Concept Videos
Pedigree Analysis
Vitamins
Inborn Errors of Metabolism
Lysosomal Hydrolases